Latest from Incanthera

Press Coverage

 May 27th, 2021 Incanthera is developing innovative technologies for oncology and dermatology
 May 18th, 2021 Incanthera cheers “very important first year”
 May 18th, 2021 Incanthera present results of first full year as public company on AQSE
 March 23rd, 2021 Incanthera fundraise oversubscribed as it focuses on Sol deal